Effect of lipoxygenase inhibitors on release of slow-reacting substances from human lung.
D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; D012898:Autacoids / Q000378:metabolism*; D002396:Catechols / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D016859:Lipoxygenase Inhibitors; D008168:Lung / Q000187:drug effects* / Q000502:physiology; D009637:Masoprocol; D011720:Pyrazoles / Q000494:pharmacology*; D013189:SRS-A / Q000378:metabolism
D012898:Autacoids; D002396:Catechols; D004791:Enzyme Inhibitors; D016859:Lipoxygenase Inhibitors; D011720:Pyrazoles; D013189:SRS-A; D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; D009637:Masoprocol